CCEL Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

7.70M

-4.04%

-0.090

-64.64%

7.60M

-4.63%

-0.090

-267.6%

7.50M

-5.06%

-0.090

-292.31%

Estimates Revision

The market is revising Upward the revenue expectations for Cryo-Cell International, Inc. (CCEL) for FY2025, with the revenue forecasts being adjusted by 0.15% over the past three months. During the same period, the stock price has changed by -19.68%.

Revenue Estimates for FY2025

Revise Upward

+0.15%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-19.68%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Cryo-Cell International Inc (CCEL.A) is -8.79, compared to its 5-year average forward P/E of 20.09. For a more detailed relative valuation and DCF analysis to assess Cryo-Cell International Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

20.09

Current PE

-8.79

Overvalued PE

119.67

Undervalued PE

-79.49

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

13.37

Current EV/EBITDA

12.76

Overvalued EV/EBITDA

22.34

Undervalued EV/EBITDA

4.40

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.34

Current PS

0.91

Overvalued PS

2.12

Undervalued PS

0.56

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

CCEL News & Events

Events Timeline

No data

News

9.5

2025-10-16NASDAQ.COM

Cryo-Cell International Inc Reports Decrease in Q3 Profit

5.0

2025-09-12NASDAQ.COM

Insider Buying Update for Friday, September 12: CCEL, AROW

8.0

2025-05-08Newsfilter

Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend

People Also Watch

Frequently Asked Questions

What is Cryo-Cell International Inc (CCEL) stock price today?

The current price of CCEL is 3.55 USD — it has decreased -1.66 % in the last trading day.

What is Cryo-Cell International Inc (CCEL)'s business?

Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.

What is the price predicton of CCEL Stock?

Wall Street analysts forecast CCEL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCEL is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cryo-Cell International Inc (CCEL)'s revenue for the last quarter?

Cryo-Cell International Inc revenue for the last quarter amounts to 7.83M USD, decreased -2.99 % YoY.

What is Cryo-Cell International Inc (CCEL)'s earnings per share (EPS) for the last quarter?

Cryo-Cell International Inc. EPS for the last quarter amounts to 0.09 USD, decreased -30.77 % YoY.

What changes have occurred in the market's expectations for Cryo-Cell International Inc (CCEL)'s fundamentals?

How many employees does Cryo-Cell International Inc (CCEL). have?

Cryo-Cell International Inc (CCEL) has 82 emplpoyees as of January 10 2026.

What is Cryo-Cell International Inc (CCEL) market cap?

Today CCEL has the market capitalization of 28.60M USD.